ElizabethAnneStreetenMD

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Parathyroid

Associate Professor, Medicine, University of Maryland School of Medicine

Dr. Streeten is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Office
Howard Hall 567, University of Maryland School of Medicine
660 W Redwood St
Baltimore, MD 21201
Phone+1 410-706-1627
Is this information wrong?

National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
Johns Hopkins University School of MedicineFellowship, Clinical Biochemical Genetics, 1985 - 1986
Johns Hopkins University School of MedicineInternship, 1982 - 1985
Albany Medical CollegeClass of 1982

PubMed

Vitamin D Deficiency Increases Vulnerability to Canagliflozin-induced Adverse Effects on 1,25-Dihydroxyvitamin D and PTH.
Zhinous Shahidzadeh Yazdi, Elizabeth A Streeten, Hilary B Whitlatch, May E Montasser, Amber L Beitelshees, Simeon I Taylor> ;The Journal of Clinical Endocrinology and Metabolism. 2024 Jan 18
Vitamin D deficiency increases vulnerability to canagliflozin-induced adverse effects on 1,25-dihydroxyvitamin D and PTH.
Zhinous Shahidzadeh Yazdi, Elizabeth A Streeten, Hilary B Whitlatch, May E Montasser, Amber L Beitelshees, Simeon I Taylor> ;Medrxiv. 2023 Aug 28
1 citations
Pharmacogenetics of sodium-glucose co-transporter-2 inhibitors: Validation of a sex-agnostic pharmacodynamic biomarker.
Simeon I Taylor, Hua-Ren Cherng, Zhinous Shahidzadeh Yazdi, May E Montasser, Hilary B Whitlatch, Braxton D Mitchell, Alan R Shuldiner, Elizabeth A Streeten, Amber L Be...> ;Diabetes, Obesity & Metabolism. 2023 Dec 1
Pharmacogenetics of SGLT2 Inhibitors: Validation of a sex-agnostic pharmacodynamic biomarker.
Simeon I Taylor, Hua-Ren Cherng, Zhinous Shahidzadeh Yazdi, May E Montasser, Hilary B Whitlatch, Braxton D Mitchell, Alan R Shuldiner, Elizabeth A Streeten, Amber L Be...> ;Medrxiv. 2023 Jun 12
Join now to see all